Stockscreener 앱 받기
0.38%
시간 외 거래:
전일 마감가:
$310.86
열려 있는:
$310
하루 거래량:
1.75M
Relative Volume:
1.00
시가총액:
$83.36B
수익:
$254.47B
순이익/손실:
$5.03B
주가수익비율:
17.28
EPS:
18.06
순현금흐름:
$6.01B
1주 성능:
-0.20%
1개월 성능:
-7.46%
6개월 성능:
-7.62%
1년 성능:
-6.27%
1일 변동 폭
$308.39
$312.10
1주일 범위
$308.39
$316.99
52주 변동 폭
$262.03
$370.82
시그나 Stock (CI) Company Profile
명칭
Cigna Group
전화
(860) 226-6000
주소
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
CI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
312.05 | 83.53B | 254.47B | 5.03B | 6.01B | 18.06 |
|
UNH
Unitedhealth Group Inc
|
298.17 | 269.12B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
380.53 | 86.87B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CVS
Cvs Health Corp
|
62.78 | 76.18B | 378.96B | 5.28B | 5.94B | 4.19 |
|
CNC
Centene Corp
|
56.52 | 28.90B | 163.07B | 3.31B | -490.00M | 6.24 |
시그나 Stock (CI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-06 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2024-02-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-01-04 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-06-06 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-22 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Hold |
| 2022-05-27 | 재개 | Bernstein | Mkt Perform |
| 2022-05-26 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-05-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-05-09 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2022-02-07 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-17 | 개시 | Seaport Research Partners | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-10 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-08-06 | 재확인 | BofA Securities | Buy |
| 2021-08-06 | 재확인 | Citigroup | Buy |
| 2021-08-06 | 재확인 | Deutsche Bank | Buy |
| 2021-08-06 | 재확인 | Jefferies | Buy |
| 2021-08-06 | 재확인 | Mizuho | Buy |
| 2021-08-06 | 재확인 | Oppenheimer | Outperform |
| 2021-08-06 | 재확인 | Truist | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-04 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-08-06 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | 개시 | UBS | Buy |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-24 | 개시 | Edward Jones | Buy |
| 2018-03-13 | 개시 | Bernstein | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Overweight |
| 2018-01-03 | 개시 | Goldman | Neutral |
| 2017-11-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-22 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-06-12 | 개시 | Credit Suisse | Outperform |
| 2017-06-07 | 개시 | Morgan Stanley | Overweight |
| 2017-05-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-04-05 | 개시 | Deutsche Bank | Buy |
모두보기
시그나 주식(CI)의 최신 뉴스
Express Scripts sues to block Arkansas law barring PBM ownership of pharmacies - marketscreener.com
Cigna study: High health insurance literacy associated with improved vitality, work productivity, and health outcomes - The Business Journals
The Cigna Group (NYSE:CI) Passed Our Checks, And It's About To Pay A US$1.51 Dividend - simplywall.st
Why You Might Be Interested In The Cigna Group (NYSE:CI) For Its Upcoming Dividend - Yahoo Finance
2 Reasons to Like CI and 1 to Stay Skeptical - FinancialContent
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now? - Yahoo Finance
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends - Yahoo Finance
Cigna’s SWOT analysis: stock poised for growth amid healthcare challenges - Investing.com
UBS Maintains Buy Rating on Cigna (CI) Stock - Insider Monkey
Molson Coors and Cigna Head My “Do Nothing” Stock List - TribLIVE.com
UBS maintains Cigna stock Buy rating with $390 target - Investing.com
Top Research Reports for Costco, Chubb & Cigna - Yahoo Finance
Guggenheim Reiterates Buy Rating for Cigna Group (CI) with $388 Price Target | CI Stock News - GuruFocus
Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy - Business Wire
Cigna's (CI) Evernorth Secures Open Access for Key Products | CI Stock News - GuruFocus
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs - MSN
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden CrackdownCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Cigna is putting a cap on weight loss drug costs - Yahoo Finance
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Pat - GuruFocus
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Patients | CI Stock News - GuruFocus
Cigna (CI) Expands Access to Weight Loss Medications with New Ph - GuruFocus
Cigna (CI) Unit Launches Cost-Effective Pharmacy Benefit for Wei - GuruFocus
Cigna (CI) Launches Cost-Effective Benefit Option for Weight Loss Drugs | CI Stock News - GuruFocus
Cigna (CI) Caps Weight-Loss Drug Costs, Impact on Telehealth Offerings | CI Stock News - GuruFocus
Former employees sue Cigna's 401(k) fiduciaries for misusing forfeited employer match money - Pensions & Investments
Pharmalittle: We're reading about rising drug prices, Cigna's plan for weight loss drugs, and more - statnews.com
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - Reuters
Cigna (CI) Launches Cost-Capping Program for Weight-Loss Drugs - GuruFocus
Cigna’s Evernorth caps weight-loss drug copays at $200/month (CI:NYSE) - Seeking Alpha
Cigna Offers New Weight-Loss Drug Pricing Plan to Boost Use - Bloomberg
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs - MSN
Cigna (CI) Faces Increased Scrutiny Amid Expanded Medicare Audits | CI Stock News - GuruFocus
Cigna Group's Evernorth Launches Benefit Option to Lower Weight Loss Medicine Costs - marketscreener.com
Cigna (CI) Affected by Medicare Advantage Audit Expansion | CI Stock News - GuruFocus
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month - Quantisnow
Cigna Accused of Misusing Retirement Plan Funds - USA Herald
Baird Adjusts Price Target on Cigna Group to $364 From $362, Maintains Outperform Rating - marketscreener.com
Cigna Accused Of Mismanaging Retirement Plan Funds - Law360
2nd Circ. Affirms Dismissal Of Lab's Payment Suit Against Cigna - Law360
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years - Benzinga
Cigna Group (CI) Reaffirms 2025 Financial Outlook - GuruFocus
Cigna Reaffirms 2025 Earnings Projection Amid Investor Meetings - TipRanks
Virtual-Care Company Omada Files IPO Papers - Healthcare Innovation
Forfeiture Lawsuit Filed Against Cigna; Intuit Reaches Settlement - planadviser
Cigna employees file a 401(k) lawsuit, alleging misuse of forfeited funds - BenefitsPRO
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Cigna Hit With Forfeiture Lawsuit; Intuit Reaches Settlement - plansponsor
Trump’s Drug Pricing Order Targets PBMs—Pharma Stocks May Escape the Worst - Investing.com
CI Q1 Earnings Call: Cigna Delivers Revenue Beat and Focuses on Healthcare Innovation - Yahoo Finance
Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud - WSJ
시그나 (CI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.68%
자본화:
|
볼륨(24시간):